1 to 10 of 204
Sort by

Library Entry
Advances in Cancer Immunotherapy™ Webinar Series: Updates from the Field - Clinical Updates from SITC 2018

This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers Christian M. Capitini, MD, and Zachary S. Morris,...

Library Entry
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article the PARP inhibitor olaparib was combined with durvalumab to treat mCRPC, regardless of patients’ mutational status. Authors: Fatima Karzai , David VanderWeele , Ravi A. Madan , Helen Owens , Lisa M. Cordes ...

Library Entry
Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results

Published in the Journal for ImmunoTherapy of Cancer (JITC), is an update on long-term survival results from two single-arm, phase II adjuvant trials (Trial 3 and Trial 5) with the focus on treatment beyond recurrence of the disease. Authors: Jacek Mackiewicz , Tomasz Burzykowski , Dariusz...

Library Entry
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article that reports the evaluation of a next generation STAT3 ASO (AZD9150) in a non-Hodgkin’s lymphoma population, primarily consisting of patients with DLBCL. Authors: Matthew J. Reilley , Patricia McCoon , Carl...

5th Forum on Immunotherapy and Translational Immunology of Cancer (FIT Cancer V)

Presented by the Spanish Group for Immuno-Biological Therapies in Cancer (GÉTICA) in collaboration with the Society for Immunotherapy of Cancer (SITC). FIT-Cancer V is an educational program focused on facilitating the exchange of knowledge between immunologists and clinicians, to enable...

 03-07-2019 00:00 - 03-09-2019 23:55 CET

11th Breast-Gynecological & Immuno-Oncology International Cancer Conference (BGIICC)

The 11th Breast, Gynecological and Immuno-oncology International Cancer Conference (BGIICC) is the only conference specialized in breast gynecological cancers in Africa and the Middle-East. The 2019 Scientific Program is designed to give a good platform for the exchange of experience on cancers...

 01-17-2019 00:00 - 01-18-2019 23:55 EET
 Cairo Governorate

Library Entry
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Published in the Journal for ImmunoTherapy of Cancer, is a research article about 3-year outcomes from the open-label, parallel-cohort, dose-escalation, phase I CheckMate 016 study of patients with aRCC treated with a combination of nivolumab and the TKIs sunitinib or pazopanib. Authors: Asim...

Library Entry
LUNGevity: Video Library

Learn more about immunotherapy and targeted therapies for the treatment of lung cancer, and hear from lung cancer survivors on LUNGevity's video library. Click here to explore LUNGevity's video library. #ClinicalTrials #Biomarkers #LungCancers #Non-SmallCellLungCancer #Small...